Status:
TERMINATED
Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) Laser Treatment for Granular Corneal Dystrophy
Lead Sponsor:
Johns Hopkins University
Conditions:
Granular Dystrophy, Corneal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Granular Corneal Dystrophy is a rare hereditary disease characterized by the development of deposits within the cornea, which may in turn affect the quality of vision. Still today, all existing treatm...
Detailed Description
Neodymium:yttrium aluminum garnet (Nd:YAG) laser is an ophthalmic instrument that finds versatile use in clinical practice since its first introduction in 1980s. This solid-state laser emits infrared ...
Eligibility Criteria
Inclusion
- Patients older than 18 years of age
- Diagnosis of granular corneal dystrophy with presence of granular opacities in the peripheral cornea of appropriate size (ca. 50 µm) in at least one eye
- Willingness and ability to give signed informed consent and follow study instructions
Exclusion
- Presence of any active intra-ocular inflammation
- Pre-existing glaucoma or retinal edema
- Cannot properly self-administer or receive an eye drop medication
Key Trial Info
Start Date :
January 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2024
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT06202651
Start Date
January 26 2022
End Date
December 9 2024
Last Update
January 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilmer Eye Institute - Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287